DPP4 and atrial fibrillation: Ostropolets et al. [4] observed reduced atrial arrhythmias, including AF, with metformin monotherapy compared to sulfonylureas and DPP4 inhibitors, but cautioned against metformin–sulfonylurea combination therapy.